Brief: ChromoGenics Q4 Operating Loss Widens To SEK 13.2 Mln
08/03/2024 07:45
March 8 (Reuters) - ChromoGenics AB CHRO.ST :
* ORDER INTAKE FOR Q4 2023 WAS SEK 6.6 (2.8) MILLION
* Q4 NET SALES AMOUNTED TO SEK 2.5 (3.5) MILLION
* Q4 OPERATING PROFIT BEFORE DEPRECIATION/AMORTIZATION
AMOUNTED TO
SEK -13.2 (-10.4) MILLION
Source text for Eikon: ID:nWkrbHgLll
Further company coverage: CHRO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChromoGenics AB
See all newsBrief: Chromogenics Says Conditional Loan Of SEK 47.6 Mln Is Converted To Grant
Brief: Färna Invest Makes SEK 10/Shr Offer For Chromogenics
Brief: Chromogenics Q1 Pre-Tax Loss Widens To SEK 13.6 Mln
Brief: Chromogenics Gets First Order For North America
Brief: Chromogenics Initiates Cost Reduction Program